Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [4] - Bee Assistant plans to raise no more than 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [5] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Three squirrels have received approval from the China Securities Regulatory Commission for H-share issuance, with plans to issue up to 81.5483 million shares [7] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [8] Group 2 - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind, solar, and energy storage [9] - Sains plans to invest no more than 300 million yuan in the expansion of its selection agent project [10] Group 3 - Hunan YN reports no significant changes in its internal and external operating environment [11] - Electric Power Investment has had its major asset replacement review suspended by the Shenzhen Stock Exchange due to expired financial documents [12] - Guanzhong Ecological is in the planning stage for acquiring a 51% stake in Hangzhou Actuary [13][14] Group 4 - Aima Technology's subsidiary is transferring production capacity and ceasing operations due to strategic adjustments [17] - Fosun Pharma's subsidiary has received approval for clinical trials of a new drug [18] - SAIC Group's subsidiary plans to invest 666 million yuan in the restructuring of SAIC Hongyan [19] Group 5 - Hanwei Technology plans to sell 65% of Hanwei Zhiyuan for approximately 440 million yuan [20] - Xingtong Co. has been awarded new capacity for coastal inter-provincial bulk liquid hazardous goods transportation [21][22] Group 6 - EVE Battery Investment received a cash dividend of 375 million HKD from its associate company [23] - Shanmei International's chairman has resigned due to work changes [24] - Weiye Co.'s chairman has resigned for personal reasons [25] Group 7 - Jiao Da Sino's chairman has been placed under detention [26] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [27][28] - *ST Zhengping's stock has been suspended for investigation due to abnormal price fluctuations [29] Group 8 - Zhenray Technology's chairman has had detention measures lifted [30] - Shiming Technology's chairman has had detention measures changed to a warning [31] - Nanxin Pharmaceutical is under investigation by the CSRC for suspected violations in annual report disclosures [32] Group 9 - Daqian Ecology's shareholder plans to reduce holdings by up to 3% [33] - Rundar Medical's shareholders plan to reduce holdings by up to 2.99% [34][35] - Saili Medical's shareholder plans to reduce holdings by up to 2% [36] Group 10 - Huaxin Environmental plans to repurchase shares for 40 to 80 million yuan [37] - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [38] - Zhongwu Drone has signed a significant contract worth 615 million yuan for drone systems [39]

Group 1 - Company Chairman Li Wei has been placed under detention, and Vice General Manager Zhang Min will assume his responsibilities [1][2] - The company held a board meeting on September 29, 2025, to authorize Zhang Min to act as the Chairman and legal representative until Li Wei resumes his duties or a new appointment is made [2] - The company maintains that its operational management is normal and that other board members and senior management are fulfilling their roles [2] Group 2 - Company revenue for the first half of the year was 128 million yuan, a year-on-year decline of 18.48%, with net profit attributable to shareholders at 12.19 million yuan, down 51.64% [4] - The company has consistently maintained annual revenue around 300 million yuan [4] - Founded in 2001, the company specializes in rail transit, focusing on control system equipment such as responder systems and train signal devices [4]

Core Viewpoint - The company, Jiao Da Si Nuo, announced that its chairman, Li Wei, has been placed under detention by the Tianjin Binhai New Area Supervisory Committee, which affects his ability to perform his duties [1] Group 1: Company Governance - The board of directors held a meeting on September 29 to appoint Zhang Min, the company's vice president, to temporarily assume the responsibilities of the chairman and legal representative [1] - Zhang Min is authorized to sign major contracts, bidding documents, and periodic reports on behalf of the company during this interim period [1] - The duration of Zhang Min's appointment will last until Li Wei resumes his duties or a new chairman is elected [1] Group 2: Operational Stability - The company asserts that its operational management remains normal and that other board members and senior management are fulfilling their responsibilities as usual [1] - The board of directors continues to perform its duties in accordance with legal requirements, ensuring stability in governance and operations [1]

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]

Core Points - The chairman of the company, Li Wei, has been placed under detention by the Tianjin Binhai New Area Supervisory Committee, temporarily unable to fulfill his duties [1] - To ensure normal operations and decision-making, the board of directors appointed Zhang Min, the deputy general manager, to act as chairman and legal representative until Li Wei resumes his duties or a new appointment is made [1] - The company maintains a robust governance structure and internal control mechanisms, with daily operations managed by the executive team, and all other board members and senior management are performing their duties normally [1] Company Operations - The company held a board meeting on September 29, 2025, to address the situation and ensure continuity in leadership [1] - As of the announcement date, the company has not received further updates regarding the progress or conclusion of the detention matter [1] - The company will continue to monitor the situation and will fulfill its information disclosure obligations as required by relevant laws and regulations [1]

Core Viewpoint - The company, Jiao Da Si Nuo, announced that its chairman, Li Wei, has been placed under detention by the Tianjin Binhai New Area Supervisory Committee, which prevents him from fulfilling his duties as chairman [1] Group 1: Company Governance - To ensure normal operations and decision-making, the board of directors appointed Zhang Min, the deputy general manager, to act as chairman and legal representative until Li Wei resumes his duties or a new appointment is made [1] - The company maintains a robust governance structure and internal control mechanisms, with daily management handled by the executive team [1] - All other directors and senior management are performing their duties normally, and the board is fulfilling its responsibilities in accordance with the law [1] Group 2: Operational Status - As of the announcement date, the company reports that its production and operational management are functioning normally [1] - The company is monitoring the situation closely and will make appropriate arrangements while adhering to legal disclosure requirements [1]

Group 1 - The company, Jiao Da Si Nuo (300851.SZ), announced that its chairman, Mr. Li Wei, has been placed under detention as per a notice issued by the Tianjin Binhai New Area Supervisory Committee [1] - The notification regarding Mr. Li Wei's detention was communicated to the company by his family [1]

Core Viewpoint - The company announced that its chairman, Li Wei, has been placed under detention by the Tianjin Binhai New Area Supervisory Committee, leading to a temporary change in leadership responsibilities [1] Group 1: Leadership Changes - The board of directors has appointed Zhang Min, the company's vice president, to assume all responsibilities of the chairman and legal representative [1] - Zhang Min is also authorized to sign major contracts, bidding documents, and periodic reports on behalf of the company [1] - The delegation of responsibilities will remain in effect until Li Wei resumes his duties or a new officer is elected [1] Group 2: Company Operations - The company's production and operational management are reported to be normal despite the leadership change [1] - Other board members and senior management are continuing to perform their duties as usual [1] - The board of directors is fulfilling its responsibilities in accordance with legal requirements [1]

Core Viewpoint - The company, Jiaoda Sinno (300851.SZ), has announced that its chairman, Mr. Li Wei, has been placed under detention by the Tianjin Binhai New Area Supervisory Committee, which affects his ability to perform his duties [1] Group 1 - The company held its eighth meeting of the fourth board of directors on September 29, 2025, to address the situation regarding the chairman [1] - Mr. Zhang Min, the company's vice president and director, has been appointed to assume all responsibilities of the chairman and legal representative, as well as the roles in relevant board committees [1] - The delegation of responsibilities will remain in effect until Mr. Li Wei resumes his duties or a new appointment is made [1]

证券代码：300851 证券简称：交大思诺 公告编号：2025-041 1、北京交大思诺科技股份有限公司(以下简称"公司")第四届董事会第八 次会议通知于 2025 年 9 月 28 日通过书面通知、电话通知等形式送达全体董事， 同时列明了会议的召开时间、内容和方式。 2、本次董事会于 2025 年 9 月 29 日在公司会议室召开，以现场结合通讯表 决方式进行。 3、本次董事会应出席董事 6 名，实际出席董事 5 名，缺席董事 1 人（董事 长李伟先生因暂不能正常履职，缺席本次会议），参会全体董事同意豁免本次会 议通知期限。 4、本次会议由公司半数以上董事推举董事张民先生主持，公司部分高级管 理人员列席了本次董事会。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法 律法规和《北京交大思诺科技股份有限公司章程》的有关规定。 二、董事会会议审议情况 北京交大思诺科技股份有限公司 第四届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 会同意由公司董事、副总经理张民先生代为履行公司董事长、法定代表 ...